Illuminating Actionable Insights From Complex Medical Data with the Sorcero AI Platform™
The pharmaceutical industry invests billions in drug development and research, but the journey doesn’t end with regulatory approval. Post-approval, medical affairs teams in life sciences companies bridge the gap between clinical research and commercial activities. These teams leverage scientific expertise to support product development, educate healthcare professionals, and maintain regulatory compliance. However, the tools and solutions available to these teams often fall short, resulting in slow, siloed processes and delayed discoveries. Sorcero addresses this challenge by using AI to help doctors, patients, and drug manufacturers uncover medical insights faster, ultimately resulting in better patient outcomes worldwide.
The problem Sorcero tackles is monumental. In oncology alone, over 4,000 new publications emerge every week – a volume that would require dozens of full-time professionals just to read the abstracts. This data overload creates significant bottlenecks in the healthcare industry, leading to missed opportunities, inefficient use of expertise, communication breakdowns, slower innovation, and increased costs.
Recognizing the urgent need for a solution, Sorcero has developed a suite of AI-powered tools designed to empower medical affairs teams and bridge the gap between groundbreaking research and its practical application in patient care.
In an era of rapidly expanding medical knowledge, Sorcero stands at the forefront of innovation, leveraging cutting-edge AI technology to transform how the healthcare industry processes, analyzes, and utilizes vast amounts of medical data. As a trailblazer in Medical Insights Management (MIM), Sorcero addresses one of the most pressing challenges faced by medical affairs organizations worldwide: the overwhelming deluge of scientific information that threatens to impede progress in healthcare delivery and patient outcomes.
At the heart of Sorcero’s innovative approach is the Sorcero MIM solution. This comprehensive solution unifies and organizes both structured and unstructured medical data from diverse sources into a single, collaborative platform. By consolidating this information, Sorcero enables medical affairs teams to extract more value from their data, facilitating faster and more informed decision-making to drive medical strategy.
One of the most exciting features of the MIM platform is the Instant Insights Engine™. This AI-powered tool utilizes advanced natural language processing to allow users to query their data using simple language, mimicking the experience of consulting with an expert colleague. By enabling medical professionals to ask complex questions and receive high-quality, evidence-based answers instantly, Sorcero is dramatically accelerating the pace at which critical medical knowledge can be accessed and applied.
Sorcero’s commitment to innovation is further exemplified by the introduction of Scientific Sentiment™, a groundbreaking feature that quantifies product perception across key opinion leaders (KOLs), healthcare providers (HCPs), and the market. This tool provides medical affairs teams with a deeper understanding of efficacy and safety information, allowing them to measure trends, identify evidence gaps, and quantify the ROI of outreach efforts.
Recognizing the growing demand for accessible medical information, Sorcero has also developed Sorcero PLS™ for Plain Language Summaries. An AI-powered tool that automatically generates high-quality, patient-accessible summaries of scientific publications. This innovative solution not only reduces the manual workload for medical writers but also plays a crucial role in bridging the gap between complex medical information and patient understanding. By producing summaries that are more readable than the industry average, Sorcero is directly addressing the health literacy challenge, where nearly 9 out of 10 adults lack the skills needed to manage their health effectively.
The impact of Sorcero’s innovations has been remarkable. In collaboration with industry leaders like UCB and Lumanity, Sorcero’s PLS solution has increased the readability of medical literature from under 1% to an impressive 51% for both patients and providers. Furthermore, Sorcero PLS abstracts have been rated higher in quality by subject matter experts compared to manually written ones, with physicians preferring the AI-generated outputs for use with patients.
The excitement surrounding Sorcero’s contributions to the healthcare industry is palpable. Their platform is utilized by 23% of the top global pharmaceutical companies, a testament to its value and reliability in the life sciences sector. This widespread adoption is accelerating the dissemination of critical medical information and empowering patients to participate more actively in their healthcare decisions.
Sorcero’s innovative approach has not gone unnoticed. Fast Company recognized the company as the #1 Most Innovative Company in the Small and Mighty category for 2024, validating their impact on the industry and potential for future growth. Strategic partnerships with industry leaders have further expanded Sorcero’s reach and capabilities, enabling them to leverage advanced AI technologies while ensuring responsible AI use in life sciences. As Sorcero continues to push the boundaries of what’s possible in healthcare technology, they remain committed to their ultimate goal: improving patient outcomes and accelerating the adoption of breakthrough therapies.
